Your Unread Messages in PsychiatrySee All >> Messages include industry-sponsored communications and special communications from MDLinx
Smartest Doc Board Exam Prep
2015 ABPN Psychiatry Board Exam is 8 weeks away. Prep Now with hundreds of board-style questions!
The influence of atypical antipsychotic drugs on sexual function
MDLinx Conference Center
Start planning for the end of the year conferences. Check out the latest must attend meetings for fall and winter 2015/2016.
Top Medical News
Stay current with the latest medical news making headlines from this week
1 Aripiprazole augmentation versus antidepressant switching for patients with major depressive disorder: A 6-week, randomized, rater-blinded, prospective study Journal of Psychiatric Research, May 12, 2015
2 Dasotraline for the treatment of attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled, proof-of-concept trial in adults Neuropsychopharmacology, June 11, 2015
3 A randomized controlled trial of 6-week Chlorella vulgaris supplementation in patients with major depressive disorder Complementary Therapies in Medicine, June 24, 2015
4 Olanzapine and risperidone plasma concentration therapeutic drug monitoring: A feasibility study Journal of Psychopharmacology, June 10, 2015
5 Use of antidiabetic and antidepressant drugs is associated with increased risk of myocardial infarction: a nationwide register study Diabetic Medicine, June 8, 2015
6 Child developmental outcomes in preschool children following antidepressant exposure in pregnancy Australian and New Zealand Journal of Psychiatry, June 26, 2015
7 Effects of glutamate positive modulators on cognitive deficits in schizophrenia: A systematic review and meta-analysis of double-blind randomized controlled trials Molecular Psychiatry, June 23, 2015 Free full text Evidence Based Medicine
8 Antidepressant dose and treatment response in bipolar depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) data Journal of Psychiatric Research, June 29, 2015
9 Risk of Parkinson's disease following anxiety disorders: a nationwide population-based cohort study European Journal of Neurology, June 18, 2015
10 Phase 2 trial of an alpha-7 nicotinic receptor agonist (TC-5619) in negative and cognitive symptoms of schizophrenia Schizophrenia Bulletin, June 19, 2015
© 2015 M3 USA Corporation. ALL Rights Reserved.